PubRank

Cristiano Capurso

Author PubWeight™ 65.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry 2010 2.22
2 Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry 2005 1.63
3 Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging 2005 1.46
4 Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 2010 1.30
5 Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis 2010 1.23
6 Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp Gerontol 2005 1.06
7 Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother 2008 1.06
8 Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta 2005 1.03
9 Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging 2009 1.02
10 Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev 2008 1.00
11 Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiol Aging 2005 0.99
12 Lipid metabolism in cognitive decline and dementia. Brain Res Rev 2006 0.98
13 Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes. J Alzheimers Dis 2009 0.98
14 Depressive symptoms, vascular risk factors and mild cognitive impairment. The Italian longitudinal study on aging. Dement Geriatr Cogn Disord 2008 0.96
15 Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging 2009 0.96
16 Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis 2010 0.96
17 Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging. J Alzheimers Dis 2009 0.96
18 REVIEW: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current state. CNS Neurosci Ther 2010 0.96
19 Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging. Int J Geriatr Psychiatry 2008 0.95
20 Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry 2009 0.93
21 Mediterranean diet, mild cognitive impairment, and Alzheimer's disease. Exp Gerontol 2006 0.92
22 Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms. Ageing Res Rev 2009 0.92
23 Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. J Alzheimers Dis 2010 0.91
24 Lipoproteins, vascular-related genetic factors, and human longevity. Rejuvenation Res 2007 0.90
25 Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians. Neuroreport 2003 0.89
26 Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on aging. Dement Geriatr Cogn Disord 2007 0.89
27 Vascular genetic factors and human longevity. Mech Ageing Dev 2004 0.88
28 Heterogeneity of mild cognitive impairment and other predementia syndromes in progression to dementia. Neurobiol Aging 2006 0.87
29 Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia. Dement Geriatr Cogn Disord 2007 0.87
30 Nutritional factors, cognitive decline, and dementia. Brain Res Bull 2005 0.86
31 Higher total cholesterol, cognitive decline, and dementia. Neurobiol Aging 2008 0.85
32 Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein. Aging Clin Exp Res 2009 0.85
33 Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging. Exp Gerontol 2006 0.83
34 Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease. J Am Geriatr Soc 2007 0.82
35 Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe. Exp Gerontol 2003 0.81
36 Adherence to a Mediterranean dietary pattern and risk of Alzheimer's disease. Ann Neurol 2006 0.81
37 Effect of donepezil on the continuum of depressive symptoms, mild cognitive impairment, and progression to dementia. J Am Geriatr Soc 2010 0.81
38 Apolipoprotein E, dementia, and human longevity. J Am Geriatr Soc 2009 0.81
39 Selective attention skills in differentiating between Alzheimer's disease and normal aging. J Geriatr Psychiatry Neurol 2002 0.80
40 Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus. Atherosclerosis 2005 0.80
41 Diet, cholesterol metabolism, and Alzheimer's disease: Apolipoprotein E as a possible link? J Am Geriatr Soc 2006 0.80
42 Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer's disease. J Alzheimers Dis 2009 0.80
43 Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease. Neurobiol Aging 2005 0.80
44 Candidate genes for late-onset Alzheimer's disease: focus on chromosome 12. Mech Ageing Dev 2005 0.79
45 Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: a review. ScientificWorldJournal 2009 0.79
46 Mediterranean dietary pattern, mild cognitive impairment, and progression to dementia. Arch Neurol 2009 0.79
47 Unsaturated fatty acids intake and all-causes mortality: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Exp Gerontol 2005 0.79
48 Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein 1 polymorphism in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2004 0.78
49 Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =65 years of age (The Italian Longitudinal Study on Aging). Am J Cardiol 2002 0.78
50 Polymorphisms in the oxidized low-density lipoprotein receptor-1 gene and risk of Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2005 0.78
51 Dietary patterns and protection against Alzheimer disease and cognitive decline. Arch Neurol 2010 0.78
52 Dietary fatty acids and predementia syndromes. ScientificWorldJournal 2009 0.78
53 Hypertension and mild cognitive impairment subtypes. Arch Neurol 2008 0.78
54 Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline. Aging Clin Exp Res 2006 0.77
55 [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism]. Recenti Prog Med 2002 0.77
56 Whole-diet approach and risk of chronic disease: Limits and advantages. J Am Geriatr Soc 2006 0.77
57 Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages. Atherosclerosis 2006 0.77
58 Whole-diet approach: working on a criterion validity for age-related cognitive decline and mild cognitive impairment. J Am Geriatr Soc 2009 0.77
59 Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia. Dement Geriatr Cogn Disord 2010 0.77
60 Progression to dementia in probable and possible mild cognitive impairment. Arch Neurol 2007 0.77
61 Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia? J Am Geriatr Soc 2008 0.77
62 Lifestyle-related factors, alcohol consumption, and mild cognitive impairment. J Am Geriatr Soc 2007 0.76
63 Serum total cholesterol as a biomarker for Alzheimer's disease: mid-life or late-life determinations? Exp Gerontol 2006 0.76
64 Moderate alcohol consumption, apolipoprotein E, and neuroprotection. Arch Neurol 2009 0.76
65 Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia. J Alzheimers Dis 2006 0.76
66 All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a). Rejuvenation Res 2009 0.76
67 Semantic dementia: neuropsychological and behavioral patterns in relation to hemispheric asymmetries. Am J Geriatr Psychiatry 2003 0.76
68 Alcohol use, thiamine deficiency, and cognitive impairment. JAMA 2008 0.75
69 Low incidence for predementia and dementia syndromes in a brain imaging study. Ann Neurol 2006 0.75
70 Whole-diet approach, Mediterranean diet, and Alzheimer disease. Arch Neurol 2007 0.75
71 N-3 polyunsaturated fatty acids and statins in heart failure. Lancet 2009 0.75
72 Cardiovascular factors and cognitive impairment: a role for unsaturated fatty acids and Mediterranean diet? Am J Cardiol 2006 0.75
73 Possible role of unsaturated fatty acids in a 14-day healthy longevity lifestyle program. Am J Geriatr Psychiatry 2007 0.75
74 Stroke and memory decline: a question of degenerative or vascular origin. Arch Neurol 2006 0.75
75 Prevalence rates of mild cognitive impairment subtypes and progression to dementia. J Am Geriatr Soc 2006 0.75
76 Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. J Am Geriatr Soc 2008 0.75
77 Possible predictors of vascular cognitive impairment-no dementia. J Am Geriatr Soc 2009 0.75
78 S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease. Neurobiol Aging 2006 0.75
79 Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease. Neurobiol Aging 2008 0.75
80 Dietary polyunsaturated fatty acid supplementation, pre-dementia syndromes, and Alzheimer's disease. J Am Geriatr Soc 2007 0.75
81 Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging. J Am Geriatr Soc 2007 0.75
82 Molecular determinants of human longevity. Adv Clin Chem 2005 0.75
83 Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? J Rehabil Med 2009 0.75
84 [Depression in old age: a diagnostic and therapeutic challenge]. Recenti Prog Med 2007 0.75
85 [Predementia syndromes and mild cognitive impairment: diagnosis and progression to dementia]. Recenti Prog Med 2007 0.75